{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T17:54:20Z","timestamp":1782842060214,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004156","name":"Mahidol University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004156","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-025-04226-x","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:34:13Z","timestamp":1758882853000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy of a 7-day vonoprazan, sitafloxacin, and amoxicillin triple therapy as a fourth-line salvage regimen for refractory Helicobacter pylori infection"],"prefix":"10.1186","volume":"25","author":[{"given":"Tanawat","family":"Geeratragool","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supathep","family":"Tansirichaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Witchuda","family":"Kamolvit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanapat","family":"Atthakitmongkol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wasawat","family":"Leartsiwawinyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyarit","family":"Thaipisuttikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pritsana","family":"Chuenprapai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somchai","family":"Leelakusolvong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chanin","family":"Limwong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monthira","family":"Maneerattanaporn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"issue":"6","key":"4226_CR1","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1016\/S2468-1253(23)00070-5","volume":"8","author":"Y Li","year":"2023","unstructured":"Li Y, Choi H, Leung K, Jiang F, Graham DY, Leung WK. Global prevalence of Helicobacter pylori infection between 1980 and 2022: a systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2023;8(6):553\u201364.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"17","key":"4226_CR2","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMcp1001110","volume":"362","author":"KE McColl","year":"2010","unstructured":"McColl KE. Clinical practice. Helicobacter pylori infection. N Engl J Med. 2010;362(17):1597\u2013604.","journal-title":"N Engl J Med"},{"issue":"2","key":"4226_CR3","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1053\/j.gastro.2021.04.012","volume":"161","author":"T Rokkas","year":"2021","unstructured":"Rokkas T, Gisbert JP, Malfertheiner P, Niv Y, Gasbarrini A, Leja M, et al. Comparative effectiveness of multiple different First-Line treatment regimens for Helicobacter pylori infection: A network Meta-analysis. Gastroenterology. 2021;161(2):495\u2013e5074.","journal-title":"Gastroenterology"},{"issue":"6","key":"4226_CR4","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1111\/hel.12063","volume":"18","author":"D Asaoka","year":"2013","unstructured":"Asaoka D, Nagahara A, Matsuhisa T, Takahashi S, Tokunaga K, Kawai T, et al. Trends of second-line eradication therapy for Helicobacter pylori in japan: a multicenter study in the Tokyo metropolitan area. Helicobacter. 2013;18(6):468\u201372.","journal-title":"Helicobacter"},{"issue":"1","key":"4226_CR5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.3164\/jcbn.10-10","volume":"47","author":"M Sasaki","year":"2010","unstructured":"Sasaki M, Ogasawara N, Utsumi K, Kawamura N, Kamiya T, Kataoka H, et al. Changes in 12-Year First-Line eradication rate of Helicobacter pylori based on triple therapy with proton pump inhibitor, amoxicillin and clarithromycin. J Clin Biochem Nutr. 2010;47(1):53\u20138.","journal-title":"J Clin Biochem Nutr"},{"issue":"5","key":"4226_CR6","doi-asserted-by":"publisher","first-page":"1831","DOI":"10.1053\/j.gastro.2020.11.059","volume":"160","author":"SC Shah","year":"2021","unstructured":"Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review. Gastroenterology. 2021;160(5):1831\u201341.","journal-title":"Gastroenterology"},{"issue":"2","key":"4226_CR7","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/ajg.2016.563","volume":"112","author":"WD Chey","year":"2017","unstructured":"Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of Helicobacter pylori infection. Am J Gastroenterol. 2017;112(2):212\u201339.","journal-title":"Am J Gastroenterol"},{"key":"4226_CR8","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1136\/gutjnl-2022-327745","volume":"71","author":"P Malfertheiner","year":"2022","unstructured":"Malfertheiner P, Megraud F, Rokkas T, Gisbert JP, Liou JM, Schulz C, et al. Management of Helicobacter pylori infection: the Maastricht vi\/florence consensus report. Gut. 2022;71:1724\u201362.","journal-title":"Gut"},{"issue":"2","key":"4226_CR9","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1097\/MCG.0000000000001719","volume":"57","author":"P Katelaris","year":"2023","unstructured":"Katelaris P, Hunt R, Bazzoli F, Cohen H, Fock KM, Gemilyan M, et al. Helicobacter pylori world gastroenterology organization global guideline. J Clin Gastroenterol. 2023;57(2):111\u201326.","journal-title":"J Clin Gastroenterol"},{"issue":"32","key":"4226_CR10","doi-asserted-by":"publisher","first-page":"4629","DOI":"10.3748\/wjg.v25.i32.4629","volume":"25","author":"D Pohl","year":"2019","unstructured":"Pohl D, Keller PM, Bordier V, Wagner K. Review of current diagnostic methods and advances in Helicobacter pylori diagnostics in the era of next generation sequencing. World J Gastroenterol. 2019;25(32):4629\u201360.","journal-title":"World J Gastroenterol"},{"issue":"4","key":"4226_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1053\/j.gastro.2018.06.047","volume":"155","author":"JM Liou","year":"2018","unstructured":"Liou JM, Chen PY, Luo JC, Lee JY, Chen CC, Fang YJ, et al. Efficacies of genotypic resistance-guided vs empirical therapy for refractory Helicobacter pylori infection. Gastroenterology. 2018;155(4):1109\u201319.","journal-title":"Gastroenterology"},{"issue":"4","key":"4226_CR12","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s40262-015-0326-7","volume":"55","author":"H Echizen","year":"2016","unstructured":"Echizen H. The First-in-Class Potassium-Competitive acid blocker, Vonoprazan fumarate: Pharmacokinetic and pharmacodynamic considerations. Clin Pharmacokinet. 2016;55(4):409\u201318.","journal-title":"Clin Pharmacokinet"},{"issue":"3","key":"4226_CR13","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s40265-023-01991-5","volume":"84","author":"M Shirley","year":"2024","unstructured":"Shirley M, Vonoprazan. A review in Helicobacter pylori infection. Drugs. 2024;84(3):319\u201327.","journal-title":"Drugs"},{"issue":"7","key":"4226_CR14","doi-asserted-by":"publisher","first-page":"3097","DOI":"10.1128\/AAC.01552-08","volume":"53","author":"K Murakami","year":"2009","unstructured":"Murakami K, Okimoto T, Kodama M, Tanahashi J, Fujioka T, Ikeda F, et al. Sitafloxacin activity against Helicobacter pylori isolates, including those with GyrA mutations. Antimicrob Agents Chemother. 2009;53(7):3097\u20139.","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"4226_CR15","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1111\/jgh.12442","volume":"29","author":"T Furuta","year":"2014","unstructured":"Furuta T, Sugimoto M, Kodaira C, Nishino M, Yamade M, Uotani T, et al. Sitafloxacin-based third-line rescue regimens for Helicobacter pylori infection in Japan. J Gastroenterol Hepatol. 2014;29(3):487\u201393.","journal-title":"J Gastroenterol Hepatol"},{"issue":"4","key":"4226_CR16","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/hel.12286","volume":"21","author":"H Mori","year":"2016","unstructured":"Mori H, Suzuki H, Matsuzaki J, Tsugawa H, Fukuhara S, Miyoshi S, et al. Efficacy of 10-day sitafloxacin-containing third-line rescue therapies for Helicobacter pylori strains containing the GyrA mutation. Helicobacter. 2016;21(4):286\u201394.","journal-title":"Helicobacter"},{"issue":"12","key":"4226_CR17","doi-asserted-by":"publisher","first-page":"2722","DOI":"10.3390\/jcm10122722","volume":"10","author":"T Nishizawa","year":"2021","unstructured":"Nishizawa T, Munkjargal M, Ebinuma H, Toyoshima O, Suzuki H. Sitafloxacin for third-line Helicobacter pylori eradication: a systematic review. J Clin Med. 2021;10(12):2722.","journal-title":"J Clin Med"},{"issue":"1","key":"4226_CR18","first-page":"32","volume":"24","author":"S Agudo","year":"2011","unstructured":"Agudo S, P\u00e9rez-P\u00e9rez G, Alarc\u00f3n T, L\u00f3pez-Brea M. Rapid detection of clarithromycin resistant Helicobacter pylori strains in Spanish patients by polymerase chain reaction-restriction fragment length polymorphism. Rev Esp Quimioter. 2011;24(1):32\u20136.","journal-title":"Rev Esp Quimioter"},{"issue":"12","key":"4226_CR19","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1128\/AAC.47.12.3942-3944.2003","volume":"47","author":"J Tankovic","year":"2003","unstructured":"Tankovic J, Lascols C, Sculo Q, Petit JC, Soussy CJ. Single and double mutations in GyrA but not in GyrB are associated with low- and high-level fluoroquinolone resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2003;47(12):3942\u20134.","journal-title":"Antimicrob Agents Chemother"},{"issue":"1","key":"4226_CR20","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jmii.2022.07.006","volume":"56","author":"CJ Kuo","year":"2023","unstructured":"Kuo CJ, Ke JN, Kuo T, Lin CY, Hsieh SY, Chiu YF, et al. Multiple amino acid substitutions in penicillin-binding protein-1A confer amoxicillin resistance in refractory Helicobacter pylori infection. J Microbiol Immunol Infect. 2023;56(1):40\u20137.","journal-title":"J Microbiol Immunol Infect"},{"issue":"9","key":"4226_CR21","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1128\/AAC.46.9.2996-3000.2002","volume":"46","author":"MM Gerrits","year":"2002","unstructured":"Gerrits MM, de Zoete MR, Arents NL, Kuipers EJ, Kusters JG. 16S rRNA mutation-mediated Tetracycline resistance in Helicobacter pylori. Antimicrob Agents Chemother. 2002;46(9):2996\u20133000.","journal-title":"Antimicrob Agents Chemother"},{"key":"4226_CR22","doi-asserted-by":"publisher","first-page":"100636","DOI":"10.1016\/j.nmni.2019.100636","volume":"34","author":"S Rezaei","year":"2020","unstructured":"Rezaei S, Talebi Bezmin Abadi A, Mohabatti Mobarez A. Metronidazole-resistant Helicobacter pylori isolates without RdxA mutations obtained from Iranian dyspeptic patients. New Microbes New Infect. 2020;34:100636.","journal-title":"New Microbes New Infect"},{"key":"4226_CR23","first-page":"85","volume":"6","author":"C Sukasem","year":"2013","unstructured":"Sukasem C, Tunthong R, Chamnanphon M, Santon S, Jantararoungtong T, Koomdee N, et al. CYP2C19 polymorphisms in the Thai population and the clinical response to clopidogrel in patients with atherothrombotic-risk factors. Pharmgenomics Pers Med. 2013;6:85\u201391.","journal-title":"Pharmgenomics Pers Med"},{"key":"4226_CR24","doi-asserted-by":"publisher","first-page":"175628482311709","DOI":"10.1177\/17562848231170941","volume":"16","author":"SW Wang","year":"2023","unstructured":"Wang SW, Yu FJ, Kuo FC, Wang JW, Wang YK, Chen YH, et al. Rescue therapy for refractory Helicobacter pylori infection: current status and future concepts. Th Adv Gastroenterol. 2023;16:17562848231170941.","journal-title":"Th Adv Gastroenterol"},{"issue":"6","key":"4226_CR25","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s11894-011-0226-4","volume":"13","author":"G Sachs","year":"2011","unstructured":"Sachs G, Scott DR, Wen Y. Gastric infection by Helicobacter pylori. Curr Gastroenterol Rep. 2011;13(6):540\u20136.","journal-title":"Curr Gastroenterol Rep"},{"issue":"3","key":"4226_CR26","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1177\/2050640617737215","volume":"6","author":"H Mori","year":"2018","unstructured":"Mori H, Suzuki H, Matsuzaki J, Masaoka T, Kanai T. Acquisition of double mutation in GyrA caused high resistance to sitafloxacin in Helicobacter pylori after unsuccessful eradication with sitafloxacin-containing regimens. United Eur Gastroenterol J. 2018;6(3):391\u20137.","journal-title":"United Eur Gastroenterol J"},{"issue":"15","key":"4226_CR27","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.3748\/wjg.v26.i15.1733","volume":"26","author":"H Mori","year":"2020","unstructured":"Mori H, Suzuki H. Update on quinolone-containing rescue therapies for Helicobacter pylori infection. World J Gastroenterol. 2020;26(15):1733\u201344.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"4226_CR28","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/S2468-1253(23)00281-9","volume":"9","author":"TC Hong","year":"2024","unstructured":"Hong TC, El-Omar EM, Kuo YT, Wu JY, Chen MJ, Chen CC, et al. Primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region between 1990 and 2022: an updated systematic review and meta-analysis. Lancet Gastroenterol Hepatol. 2024;9(1):56\u201367.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"2","key":"4226_CR29","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.1365-2036.2011.04937.x","volume":"35","author":"JP Gisbert","year":"2012","unstructured":"Gisbert JP, Calvet X. Review article: Rifabutin in the treatment of refractory Helicobacter pylori infection. Aliment Pharmacol Ther. 2012;35(2):209\u201321.","journal-title":"Aliment Pharmacol Ther"},{"key":"4226_CR30","doi-asserted-by":"crossref","unstructured":"Sugimoto M, Hira D, Murata M, Kawai T, Terada T. Effect of antibiotic susceptibility and CYP3A4\/5 and CYP2C19 genotype on the outcome of vonoprazan-containing Helicobacter pylori eradication therapy. Antibiot (Basel). 2020;9(10).","DOI":"10.3390\/antibiotics9100645"},{"issue":"2","key":"4226_CR31","doi-asserted-by":"publisher","first-page":"e12467","DOI":"10.1111\/hel.12467","volume":"23","author":"YH Wang","year":"2018","unstructured":"Wang YH, Li Z, Wang L, Zhu-Ge LY, Zhao RL, Wu S, et al. A systematic review and meta-analysis of genotypic methods for detecting antibiotic resistance in Helicobacter pylori. Helicobacter. 2018;23(2):e12467.","journal-title":"Helicobacter"},{"issue":"3","key":"4226_CR32","doi-asserted-by":"publisher","first-page":"e12960","DOI":"10.1111\/hel.12960","volume":"28","author":"S Hu","year":"2023","unstructured":"Hu S, Zhou Y, Deng Y, Bo Y, Chen X, Yang W, et al. Characteristics of phenotypic antibiotic resistance of Helicobacter pylori and its correlation with genotypic antibiotic resistance: a retrospective study in Ningxia. Helicobacter. 2023;28(3):e12960.","journal-title":"Helicobacter"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-025-04226-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-025-04226-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T10:34:14Z","timestamp":1758882854000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-025-04226-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4226"],"URL":"https:\/\/doi.org\/10.1186\/s12876-025-04226-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the ethical principles outlined.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"664"}}